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SUMMARY 
Approximately 448 million new cases of curable STIs (Chlamydia infection, 
gonorrhoea, syphilis and trichominiasis) are reported annually with 75% to 80% occur 
in developing countries. Neisseria gonorrhoeae and Chlamydia trachomatis are two 
major STD causing pathogens. Signs and symptoms of the disease include 
conjunctivitis, urethritis, epididymitis, proctitis, and salpingitis. If untreated, infection 
leads to infertility, low fetal birth weight, premature delivery and pelvic inflammatory 
disorder. The infection can also disseminate via blood stream to other organs leading 
to pain in joints (arthritis), degeneration of heart valve, gonococcal meiningitis etc. It 
is also a leading cause of neonatal blindness. Infection due Neisseria gonorrhoeae and 
Chlamydia trachomatis also facilitates acquisition of HIV and HPV. Approximately 
70% to 80% women and 50% men remain asymptomatic. Co-infection of Chlamydia 
and Neisseria is readily reported and infection rates are higher in women in 
adolescents. Although commercial kits are available, their high cost and requirement 
of technical expertise make them far from use in developing countries like India. 
Culture method and gram stain remains the method of choice, but culture method 
takes 2-3 days for results to come before treatment could be recommended. This leads 
in persistence and spread of disease in the society. Thus WHO has recommended 
syndromic management of treatment of Chlamydia and Neisseria. There occurs 
overlap in the spectrum of symptoms due to infection by Chlamydia and Neisseria 
and with various other STI causing pathogens. Discharge and pain in lower abdomen 
are also common during pregnancy. The guidelines for syndromic management issued 
by WHO are neither specific nor sensitive for the two pathogens. Also infections by 
Chlamydia and Neisseria are highly asymptomatic thus treatment only on the basis of 
vaginal discharge syndrome not only misses out asymptomatic infections but may 
also leads to overtreatment. This further leads to increased drug costs, change in 
pattern of endogenous flora, side effects of multiple drugs and emergence of antibiotic 
resistant strains by lateral gene transfer. 
Penicillin and tetracycline were widely used antibiotics till 1980’s, but due to emergence 
of resistant strains of Neisseria, these were discontinued in most of the countries. Thus, 
newer β-lactam antibiotics like ceftriaxone, cefixime, fluoroquinolones, ciprofloxacin, 
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ofloxacin, and levofloxacin are recommended for treatment. However, Neisseria with 
reduced susceptibility towards fluoroqiuninolones, ceftriaxone and cefixime are reported 
from different parts of the world. South East Asia is reported to be the centre of origin of 
several resistant strains probably due to syndromic management of gonorrhea. 
Continuous appearance of multi drug resistant strains as well as strains resistant to new 
drugs is alarming. Thus, there is an urgent need for economic, rapid, point of care test for 
co-detection of Chlamydia and Neisseria as well as an indepth understanding of 
gonococcal antibiotic resistance mechanisms is essential for the development of new and 
effective antimicrobial agents.  
The major objective of this work was to develop an in-house PCR assay that is cost 
effective and has high sensitivity and specificity and rapid so that it can be used for 
co-detection of C. trachomatis and N. gonorrhoeae infection. Patients (n=812) having 
symptoms and expecting treatment were enrolled in the study. Using uPCR, dPCR 
and commercial assays our study suggests high prevalence of Neisseria (27.8%) and 
Chlamydia (26.3%) amongst symptomatic women seeking treatment.  Most of the 
women were from age group of 18-30 years. In-house uniplex PCR (uPCR) was 
developed and evaluated against commercially available, Roche Amplicor MWP kit 
for detection of Neisseria gonorrhoeae using unique sequence of orf1 gene as target. 
Our method was found to be 95.8% sensitive and 97.9% specific. Once uPCR was 
evaluated, dPCR was developed and standardized for co detection of Neisseria 
gonorrhoeae and Chlamydia trachomatis. Uniplex PCR for Chlamydia trachomatis 
was already established in lab against gyrA gene. Samples (n=533) were evaluated for 
dPCR against uPCR. Discrepant samples (n=24) were resolved using Roche Amplicor 
MWP Kit. Based on the concordance between uPCR and Roche assay, these samples 
were scored positive for either Chlamydia or Neisseria. As per these results the 
sensitivity of in house dPCR was found to be 85.7% (95 CI: 77.1%-92.8 %) with 
specificity of 97.3% (95 CI:  95.3%-98.5 %). 
Lack of resources and technical expertise makes diagnosis of STDs difficult in rural 
areas of India. Thus, to make our method as test of choice, PCR premix-reagents (2X) 
have been stabilized  such that assay reaction mixture can be kept at 4ºC for upto 4 
months,  making it an easy assay to be carried out in peripheral laboratories where 
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deep freezers are not  available. Further PCR amplification using gDNA isolated from 
dry swabs as mode of sample collection and transportation was also standardized. We 
found that dry swabs work equally good for collection of cervical swab samples as 
wet swabs (swabs in PBS with 1mM). Since dry swabs could be transported at room 
temperature making the method of collection and transport of the samples easy from 
remote areas to the nearest laboratory, the assay so designed will be of great use for 
easy, rapid diagnosis and surveillance programs in developing countries.  
To further enhance the sensitivity and specificity of our test, molecular beacon were 
designed against the amplified region of orf1 and gyrA gene. Since molecular beacons 
can detect single nucleotide change, it thus also enhances the specificity of the test. 
Many commercial kits like Roche MWP kit uses labeled probe as the detection 
method. Their detection method is based on indirect ELISA and thus is time 
consuming (3hrs), cumbersome and requires technical expertise. Various other 
detection assays also use molecular beacons but most of these involve automated real 
time technologies. These kits generally remain out of reach in developing countries. 
In the present study, detection of amplified PCR product is done directly in PCR tube 
using a simple to use, indigenous fluorescent based dark reader for detection. To look 
for relative load of infection, the intensity of flourescence can be measured by ELISA 
reader. Looking for flourescence by directly putting PCR tubes on dark reader is far 
less time consuming than running agarose gel and/or PCR-ELISA and requires no 
technical expertise. The prime advantage of using closed tube is it minimizes chances 
of cross contamination and carry-over contamination. The present study offers an 
easy, rapid and economical NAAT-based assay to study the burden and pattern of 
infection by Neisseria gonorrhoeae and Chlamydia trachomatis.  
Although multidrug resistance strains have been reported from Delhi and other parts of 
India, there is paucity of information on the mutational patterns of the above mentioned 
genes in these isolates. In the next objective of the work, we tried to envisage the 
plausible mechanism of antibiotic resistance in clinical isolates of Neisseria gonorrhoeae. 
Resistance could be plasmid mediated or chromosomal mediated. Plasmid mediated 
resistance in confined to penicillin and tetracycline. Mutations in various genes (gyrA, 
parC, penA, mtrR, mtrE, porB etc.) act synergistically for providing chromosomal 
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mediated resistance to Neisseria. Therefore, to understand how mutations in these genes 
contribute to resistance, we in present study explored the co-relation between mutations in 
various genes (penA, mtrR, mtrE and porB) responsible for antibiotic resistance with the 
change in MIC values for penicillin, tetracycline and ceftriaxone. Fluorescence assay and 
electrophoretic mobility shift assay were carried out to study the effect of mutations in 
MtrR on its biological activity. Attempts have been made to in-silico model the structure 
of MtrR to understand how mutations affect its interaction with DNA. Protein structure of 
wild type and mutant MtrR was compared to understand the structural effect of 
mutations.  We also studied the binding of wild type and mutant MtrR with penicillin as 
well as DNA using both in silico approach and fluorimetric assay. 
Plasmid mediated resistance to penicillin is one of the major mechanism and in India, we 
found African type of plasmid in all the resistant isolates. Multi drug chromosomal 
mediated resistance was found to be highly prevalent in clinical isolates. All the clinical 
isolates (n=28) studied carried mutation in one or more genes and played role in 
imparting resistance. PIB phenotype (88.88%; 24/27) was found to be far more prevalent 
than PIA phenotype for porB gene. None of the resistant isolate carried mutations in PIA 
phenotype (11.11%; 3/27). The mutations at G120 and A121 position of loop3 of the 
mature PorB protein has been documented for increased resistance to several antibiotics. 
Mutations either at G120/ A121 or in both amino acids was reported both in isolates 
resistant as well as reduced susceptible/susceptible for penicillin as well as tetracycline. 
A121S mutation was present in five resistant isolates only. We here report a novel 
mutation of N122K (present always along with A121S) residing in loop3 which may be 
responsible for altered pore size or permeability. 
Mutations both within and outside the transpeptidase domain (AA340-570) of penA gene 
encoding for penicillin binding protein are responsible for providing resistance for 
penicillin and other beta lactams. An insertion of aspartic acid at 346th position in 
transpeptidase domain is shown to be associated with the altered structure and acylation 
of β lactam antibiotics. All the isolates showed Asp 346 insertion and mutations F504K, 
A510V and A516G. Mutant P551L was found to be one of the most frequent mutations 
while only two isolates had H541N mutation. In our study, we also found two novel 
mutations G550R, N562L and S567. We had also observed new substitution at I566N 
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along with the previously reported mutations, thus giving rise to new mutation patterns 
(Table 6). Mosaic pattern IX (11/26; 42.3%) and II (10/26; 38.46%) were most prevalent 
patterns observed in isolates from Delhi hospitals. Isolates which carried triad of 
mutations but were PPNG negative also showed either reduced susceptibility or were 
sensitive for penicillin supporting the previous contention that single mutations at F504K, 
A510V and A516G are not responsible for development of resistance against penicillin 
and ceftraixone. It has been previously shown that substitutions at F504L and P551S lead 
to decreased penicillin acylation rates but mechanism of G542S has not been elucidated. 
Thus, in present study we had tried to elucidate mechanism using homology modeling 
and docking methods. Using crystal structure of PBP2 and modeling techniques, the 
mutant protein was generated and active sites were compared. It was observed that unlike 
wild type, serine 542 formed hydrogen bond with tyrosine 544 whose side chain points 
into the active site. This may alter the spatial arrangement of the tyrosine with respect to 
active site and thus is responsible for higher affinity of the mutant for penicillin. 
Mutations in the structural genes of Mtr operon encoding for MtrCDE efflux pump or 
its regulatory protein (MtrR) as well as in promoter region could result in increased 
efflux of drug and thereby make the cell resistant to the said drug. MtrE encodes for 
outer membrane part of the efflux pump. K181E, K191R and I429S are mutations 
found in various clinical isolates. K181 resides in non conserved region of MtrE and 
is found in resistant as well as susceptible isolates suggesting that this mutation has no 
direct contribution in imparting antimicrobial resistance. K191R and I429S mutations 
reside in conserved region of MtrE. The above mutation resides in the lining of 
intraprotomer groove of the pump which binds with the MtrC and plays role in the 
channel formation and thus the function of the pump. Comparing the resistance 
pattern of isolates, it appears that K191R substitution may be crucial in imparting high 
resistance towards penicillin and tetracycline. We also compared the MIC values for 
tetracycline in PPNG positive isolates and found that isolates with K181E and K191R 
double mutants were less susceptible in comparison to K181E and K181E and I429S 
double mutant indicating some role of K191R in resistance. 
The most common mutation observed in MtrR gene was H105Y present in 11 out of 
25 clinical isolates and was mostly coupled with A/T deletion in promoter region 
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(10/11 isolates). This mutation resides in C Terminal of the protein possessing 
dimerization domain as well as ligand binding cavity. The G45D and A39T mutations 
in DNA binding domain of MtrR protein are known to provide high resistance against 
penicillin and tetracycline. Only G45D mutation was observed in clinical isolates in 
present study. In present work L33V, a novel mutation is also observed in two 
tetracycline resistant clinical isolates along with G45D mutation. To decipher the role 
of L33V mutation, we compared the MIC values of the isolates which possess similar 
mutation pattern for rest of the genes studied (penA, mtrE, porB and mtrR promoter 
region). Thus comparing the MIC value for tetracycline we found that single mutant 
had higher MIC value of 12 µg/ml as compared to 8 µg/ml possessed by the double 
mutants. This has led us to hypothesize that L33V is not advantageous to Neisseria 
with respect to antibiotic resistance. Although mechanism of action of G45D mutant 
MtrR is well recognized (i.e abrogation of binding of the protein), no direct evidence 
elucidating the mechanism of action H105Y mutation is known. We hypothesize two 
plausible mechanisms for the action of this mutation. 
 MtrR is known to bind as homodimer to its promoter.  Mutation H105Y may 
affects the dimer formation and thus its binding with DNA. 
 H105Y may alter the binding of antibiotics in ligand binding cavity. The binding 
of antibiotics like penicillin may induces conformational change and thus its 
binding with the DNA. 
With a view to understand the functional implications of mutant MtrR, we decided to 
check whether mutations in MtrR are responsible for any conformational change in 
the protein and if so, does it affect its interaction with DNA and small ligands like 
penicillin. Therefore, to identify a plethora of processes in which MtrR has some role 
to play, we selected the following objectives:  
 Bioinformatics approach to study the change in the conformation of MtrR and 
its interaction with penicillin and promoter DNA  
 Comparative analysis of the DNA binding activity of wild type and mutant 
MtrR protein using purified protein. 
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To achieve these objectives, in-silico modelling of wild type and mutant MtrR 
proteins was carried out using swiss PDB server and Discovery studio. 
Conformational change was studied by superimposing mutant protein over wild type. 
Change in conformation majorly in Helix 1 (N terminal) and helix 4 (C terminal) was 
observed. Size of the ligand binding cavity decreased from 356 Å3 of wild type to 256 
Å3 in H105Y mutant. This change is in contrast to G45D mutant wherein a minor 
increase is observed in the volume of the cavity (364 Å3). We also observed that 
presence of penicillin has an effect on MtrR conformation and/or DNA binding as 
suggested by fluorescence spectrophotometeric results. The assays were performed 
using purified wild type and H105Y mutant MtrR titrated with increasing 
concentration of penicillin which showed shift in lambda max is more pronounced in 
case of mutant. Appearance of second peak is observed around 420 nm in case of 
H105Y mutant MtrR. Both of these results suggested altered conformation of the 
mutant. We then docked penicillin in wild type as well as H105Y mutant MtrR to 
check if penicillin affects MtrR conformation by directly binding to it.  Change in 
pose and thus interacting partners was observed in wild type and Mutant MtrR. On 
comparing the various parameters, H105Y mutant appears to possess higher affinity 
for penicillin probably due to hydrogen bond formed by substituted Tyrosine 105 thus 
stabilizing the protein penicillin complex.  
Next we checked the effect of the mutation on DNA binding of MtrR using EMSA, 
fluorescence spectrophotometeric assays and in silico analysis. Electrophoretic 
mobility gel shift assay performed using crude lysate of over expressed wild type, 
mutant G45D and mutant H105Y showed that higher concentration of mutant H105Y 
protein is required to bind with its promoter DNA to cause visible gel shift. 
Competition assays suggested that far less DNA is required to compete with mutant 
protein as compared to wild type suggesting H105Y has either low DNA binding 
affinity or increased rate of dissociation. Fluorescence spectrophotometry experiments 
clearly indicated that unlike wild type MtrR, H105Y mutant MtrR failed to bind 
effectively to its binding site on the promoter. The binding affinity of the mutated 
MtrR with promoter was about 1.13 folds lower than that of wild type. Although 
change is small, it could be possible that two mechanisms act synergistically and 
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binding is effectively altered in the presence of penicillin. Further to decipher the 
change in hydrogen bond profile of protein DNA complex assembly, MtrR was 
docked with the promoter DNA. Since homodimer binds to the promoter, we first 
docked monomers of wild type and the mutants to form homodimers. Homodimer of 
H015Y mutant was most stable energetically, but increased centre to centre distance 
between helix1 and helix 1’ of two monomers suggested altered alignment of the two 
monomers on the pseudo-repeat binding site on the DNA which may reduce its 
binding with DNA as compared to that of wild type MtrR. To check this hypothesis, 
protein DNA docking was performed using refined monomer form from the dimer 
complex. Best pose was screened using structural similarity with QacR (complexed 
with its promoter), another member of TetR family. No optimal binding pose was 
obtained for G45D mutant as expected as this amino acid is critical for DNA binding. 
For H105Y mutant, two best poses which imperfectly resembled that of wild type and 
QacR DNA complex were selected. This may be explained in the light that due to 
increased centre to centre distance, residues of helix3 are not able to reside close to 
DNA residues in second half site of pseudodirect repeat of the promoter. Hydrogen 
bond analysis shows formation of different hydrogen bond between wild type DNA 
complex and H105Y mutant DNA complex.  Based on these results, we envisage that 
although different hydrogen bonds are formed between H105Ymutant MtrR and DNA 
complex, they may be sufficient to provide only partial stability to the complex which 
may account for the observed protein-DNA binding using EMSA and fluorescence 
spectrophotometry. It remains to see whether mutation in H105Y affects the rate of 
dissociation from DNA which will indirectly result in increased expression of the operon. 
Thus even a single amino acid change outside the DNA binding domain causes a 
conformational change in the binding domain of MtrR both in the presence and 
absence of penicillin which may be responsible for altered DNA-protein interaction.  
